You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Michael Schlenk

Chief Executive Officer at curasan AG
Overview
Relationships
In The News
Paths
Education
Career History
Boards & Committees
Advisors & Consultants

Michael Schlenk

Chief Executive Officer at curasan AG

Overview

Notable Companies
curasan AG

ProBioGen AG
Board Seats
3
Number of Relationships
This person is connected to 416 people.

Relationships See Details


Chief Financial Officer at curasan AG

Head-Corporate Communications at curasan AG

Head-Marketing & Sales at curasan AG

Founder at curasan AG

Co-Founder at OXID eSales AG

Chief Executive Officer at Dr. Wilke Management & Consulting GmbH

Chief Executive Officer at Pflüger Schulz Rogalla Unternehmensberatung GmbH

Former Mitglied des Vorstands at Software AG

Partner at DPE Deutsche Private Equity GmbH

Partner at Partners för Utvecklingsinvesteringar inom Life Sciences AB
See 406 more listings with RelSci Professional.

In The News See More

GlobeNewswire
November 1, 2017
Marketwired
February 19, 2014

Paths to Michael Schlenk

Michael Schlenk
You
Connections via Relationship Science
Michael Schlenk
Sync your contacts to see how you can connect with Michael Schlenk.

Educational Background

 
We are one of the oldest university-based business schools in the UK, offering management education at undergraduate, masters, MBA, Executive Education and PhD/DBA levels for the past 50 years. One of only 59 business schools across the world with the coveted “Triple Crown” of accreditations, we are ranked amongst the world’s top business schools, have an international staff, alumni and student body and global campus.

Career History

Chief Executive Officer
2014 - Current
curasan AG engages in the developing, manufacturing, and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.
Chief Executive Officer
2003 - 2010
ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.
Head-Sales & Marketing
Prior
Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment supplies generic pharmaceuticals. The Corporate Activities segment includes other items of income and expense which are not attributable to specific segments such as certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations, and sponsorships. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees

Corporate Boards ▾
Chairman-Supervisory Board
Current
OXID eSales AG provides e-commerce software solutions and services. It offers commercial open source shopping cart software and integrates all touchpoints such as webshop, mobile, and point of sale. The firm also provides professional services from strategy development and project implementation to operation of a successful multi-channel business. The company was founded by Andrea Seeger, Roland Fesenmayr and Eric Jankowfsky in 2003 and is headquartered in Freiburg, Germany.
Member-Supervisory Board
Current
Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.
Member, Managing Board
Current
curasan AG engages in the developing, manufacturing, and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Aschaffenburg, Germany.

Advisors & Consultants

Advisor
 

Founder at curasan AG

Other Affiliations

Michael Schlenk is affiliated with curasan AG, ProBioGen AG, Novartis AG, OXID eSales AG, Centogene AG, curasan AG.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.